Epizyme
EPZM
$1.47
Share price
0.00%
Change (1 day)
-65.57%
Change (1 year)
Categories
Revenue for Epizyme (EPZM)
Revenue in 0 (TTM): N/A
According to Epizyme's latest financial reports the company's current revenue (TTM
) is $53 M.
.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Epizyme from to
Annual revenue
| Year | Revenue | Change |
|---|
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $49.92 B | 94,082.01% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $40.10 B | 75,565.94% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $37.84 B | 71,302.52% | 🇬🇧 UK |
 Seagen
SGEN | $2.30 B | 4,239.63% | 🇺🇸 USA |